B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.
JHEP Rep
; 4(5): 100460, 2022 May.
Article
en En
| MEDLINE
| ID: mdl-35368991
AIH, autoimmune hepatitis; ALT, alanine aminotransferase; AP, alkaline phosphatase; AST, aspartate aminotransferase; Autoimmune hepatitis; B-cell immunity; BAFF; BAFF, B-cell activating factor of the tumour necrosis family; Biochemical remission; GGT, gamma-glutamyltransferase; IL-21; LKM-1, liverkidneymicrosomal type 1; MRCP, magnetic resonance cholangiopancreaticography; PBC, primary biliary cholangitis; PBMC, peripheral blood mononuclear cell; PSC, primary sclerosing cholangitis; UDCA, ursodeoxycholic acid; ULN, upper limit of normal
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
JHEP Rep
Año:
2022
Tipo del documento:
Article
País de afiliación:
Países Bajos